Genomic Sequencing Should Not be Part of the Standard of Care for Most Urologic Cancers.

Journal Article (Journal Article)

There are currently few situations in which genomic testing is actionable for genitourinary tumors. Without clear indications or treatment paradigms, genomic sequencing cannot be recommended as a standard of care for genitourinary tumors.

Full Text

Duke Authors

Cited Authors

  • Abern, MR; Dudinec, JV; Inman, BA

Published Date

  • May 2022

Published In

Volume / Issue

  • 8 / 3

Start / End Page

  • 639 - 640

PubMed ID

  • 35537938

Electronic International Standard Serial Number (EISSN)

  • 2405-4569

Digital Object Identifier (DOI)

  • 10.1016/j.euf.2022.04.011


  • eng

Conference Location

  • Netherlands